Cleared Traditional

K042537 - SUBMARINE PLUS PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY (PTA) CATHETER, MODEL SUVXXXXXXXXX

K042537 is an FDA 510(k) clearance for SUBMARINE PLUS PERCUTANEOUS TRANSLUMINA..., manufactured by Invatec Innovative Technologies. The device is a Class 2 Cardiovascular device with product code DQY cleared through the Traditional 510(k) pathway after a 49-day FDA review.

K042537 · Invatec Innovative Technologies · Cardiovascular device
Download Printable Device Report (PDF) Official FDA 510(k) Summary (PDF)
Optimized for regulatory review, auditing and printing
Nov 2004
Decision
49d
Days
Class 2
Risk

K042537 is an FDA 510(k) clearance for the SUBMARINE PLUS PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY (PTA) CATHETER, MODEL SU.... Classified as Catheter, Percutaneous (product code DQY), Class II - Special Controls.

Submitted by Invatec Innovative Technologies (Plymouth, US). The FDA issued a Cleared decision on November 8, 2004 after a review of 49 days - a notably fast clearance cycle.

This device falls under the Cardiovascular FDA review panel, regulated under 21 CFR 870.1250 - the FDA cardiovascular device oversight framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Fast-track predicate clearance. Standard predicate reliance. The short review cycle indicates strong predicate alignment - the FDA found sufficient equivalence without extended technical review.

FDA 510(k) Submission Details - K042537

510(k) Number K042537 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received September 20, 2004
Decision Date November 08, 2004
Days to Decision 49 days
Submission Type Traditional
Review Panel Cardiovascular (CV)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
76d faster than avg
Panel avg: 125d · This submission: 49d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

DQY Device Classification - Class 2, Special Controls

Product Code DQY Catheter, Percutaneous
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 870.1250
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Cardiovascular devices follow this clearance model.

Regulatory Peers - DQY Catheter, Percutaneous

All 893
Devices cleared under the same product code (DQY) and FDA review panel - the closest regulatory comparables to K042537.
CORONARY SINUS VISUALIZATION SYSTEM, MODEL CSVS5508
K042381 · Acumen Medical, Inc. · Dec 2004
6F Z4 GUIDE CATHETER
K042489 · Medtronic Vascular · Dec 2004
VENTURE WIRE CONTROL CATHETER, MODEL WCC
K042910 · Velocimed, Inc. · Nov 2004
SAILOR PLUS PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY (PTA) CATHETER, MODEL SAEXXXXXXXXX
K042538 · Invatec Innovative Technologies · Nov 2004
POLARCATH PERIPHERAL BALLOON CATHETER SYSTEM
K042230 · Cryo Vascular Systems, Inc. · Nov 2004
RADIANT MEDICAL ENDOCATHETER TEMPERATURE PROBE
K042388 · Radiant Medical · Oct 2004
K042537 · SUBMARINE PLUS PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY (PTA) CATHETER, MODEL SUVXXXXXXXXX
Download PDF FDA Summary Invatec Innovative Te…